--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Dr. Bill - OHIP & MSP billing" developer_entity: "RBC Medical Billing Inc" bundle_id: "com.Pendar-Labs.Dr--Bill" app_store_id: "925900301" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2026-08-19" report_date: "2026-08-27" last_verified: "2026-08-27T00:00:00.000Z" report_version: "4.31.0" total_reviews: 6 overall_rating: 4.7 confidence: "low" confidence_score: 0.3 data_age_days: 42 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "subscription", "mobile app", "app review", "app analysis", "physicians,", "medical", "office"] canonical_url: "https://marlvel.ai/apps/dr-bill-ohip-msp-billing" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Dr. Bill - OHIP & MSP billing Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 4.67 > **TL;DR:** Dr. Bill - OHIP & MSP billing is a medical app by RBC Medical Billing Inc, rated 4.67/5 by 6 users, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Dr. Bill - OHIP & MSP billing is a medical app by RBC Medical Billing Inc. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.67/5 (6 reviews) | | **Category** | Medical | | **Developer** | RBC Medical Billing Inc | | **Pricing** | Subscription | | **Platforms** | iOS | | **Confidence** | Low (0.3/1.0) | | **Data Age** | 42d | ## Metadata & Market Performance - **Publisher:** RBC Medical Billing Inc - **Category:** Medical - **Target Audience:** Physicians, medical office assistants, and healthcare teams in Ontario, British Columbia, and Alberta. - **Platforms:** iOS - **Version Reviewed:** 4.31.0 - **Report Date:** 2026-08-27 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.3/1.0) - **App Store ID (iOS):** 925900301 - **Bundle ID:** com.Pendar-Labs.Dr--Bill - **Performance Trend:** Improving - **Data Window:** Analysis based on signals collected up to 2026-08-27 ## Executive Snapshot **What it is:** Dr. Bill is a medical billing application for physicians in Ontario, British Columbia, and Alberta that automates claim submission via smartphone camera capture. **Why users hire it:** Physicians lose significant revenue to unbilled services and claim rejections, and Dr. Bill removes the administrative friction of manual data entry to capture these lost payments. ## App DNA (Features & Intent) - **[Differentiator] LabelSnap:** Captures patient information from hospital labels via camera to auto-populate billing data, reducing entry time to 16 seconds. - **[Differentiator] Billing Agent Support:** In-house experts review claims and manage rejections with provincial ministries, gated behind the Comprehensive Plan. * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Real-time Billing Suggestions:** Built-in ministry rules provide suggestions to ensure correct code usage and premium eligibility. * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} Dr. Bill maintains a specialized position in the Canadian medical billing sector, serving physicians across three provinces. The 97% payout success rate serves as the primary differentiator against manual or legacy billing methods. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Essentials Plan for self-managed billing, Comprehensive Plan with agent-managed rejection recovery - **Analysis:** Subscription model anchored by a 3-month free trial for the Comprehensive Plan to drive new user acquisition. ## SWOT Analysis {#swot} **Core Strengths:** - LabelSnap technology reduces administrative overhead to seconds per patient - In-house billing agent support provides a high-touch recovery mechanism for rejected claims **Growth Levers:** - Expansion into remaining Canadian provinces to capture untapped physician segments - Integration with hospital EMR systems to further reduce manual data entry ## Recent Changes (v2 → v3) {#recent-changes} Dr. Bill has transitioned from a maintenance-only posture to a growth-focused strategy, prioritizing regional expansion and EMR integration to counter emerging competitive threats. **Overall trend**: Improving **Compared at**: 2026-08-27 ### High-impact changes - **[Added] Regional Expansion Priority** (swot) ### Medium-impact changes - **[Added] New Competitive Threats and Opportunities** (swot) - **[Shifted] Strategic Focus on Retention Barriers** (positioning) ## What's New - **Latest (v4.31.0, 1 weeks ago):** Routine maintenance release addressing general bug fixes and performance improvements. ## App Momentum (Maintenance) {#momentum} - Ships routine maintenance releases. - Maintains ~3-month update cadence. > **Cadence:** 2 total versions · 0 majors in last 6 months · 8 days since last update · 92 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Dr. Bill - OHIP & MSP billing is a medical app. It holds a 4.67/5 rating from 6 reviews. > **Bottom Line:** Dr. Bill's value rests on the 97% payout success rate, which makes the billing agent support the primary retention lever. Protecting this reliability against ministry code changes is essential to prevent churn among high-volume physician users. **Best for:** Physicians, medical office assistants, and healthcare teams in Ontario, British Columbia, and Alberta. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Expand regional support to additional provinces because current geographic limits cap total addressable market → increase user base ### Outlook: Stable The Canadian medical billing market is increasingly sensitive to administrative efficiency as physician workloads rise. Dr. Bill is well-positioned to maintain its current base by focusing on rejection recovery, but the lack of recent feature expansion leaves it vulnerable to EMR-integrated billing solutions. - 🟢 The 97% payout success rate provides a strong value proposition that justifies the subscription cost for time-constrained physicians. - ⚪ The current maintenance-only release cadence suggests the core product is stable, though it lacks recent feature expansion to drive new growth. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.67/5 | | Total Reviews | 6 | | Confidence | Low | | Pricing Model | Subscription | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Improving | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Dr. Bill - OHIP & MSP billing** (this app) | 4.67/5 | N/A | RBC Medical Billing Inc | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** RBC Medical Billing Inc - **Website:** [https://www.dr-bill.ca](https://www.dr-bill.ca) - **Social:** [Facebook](https://www.facebook.com/drbillapp) · [X/Twitter](https://twitter.com/drbillapp) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/dr-bill-ohip-msp-billing/id925900301?uo=4) - **Dev Site:** [Official Website](https://www.dr-bill.ca) - **Sources:** Developer website content, About us / company information, App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 42 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/dr-bill-ohip-msp-billing) Data licensed for AI Agent attribution under CC-BY-NC 4.0.